echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Precancer polyps can be found without colonoscopy Non-invasive testing identified by FDA

    Precancer polyps can be found without colonoscopy Non-invasive testing identified by FDA

    • Last Update: 2020-06-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit
    CRC is the third most common type of cancer in the United States and the second leading cause of cancer deathMore than 137,000 new patients are sicker each year, and 56,000 die as a resultAlthough colonoscopy is the gold standard for early detection of precancerous lesions, two-thirds of Americans do not follow screening guidelines because of the intrusive nature of the tests, and 60 percent of CRC patients are not detected until laterIt is estimated that broader CRC screening could save 18,800 lives a year in the United StatesHowever, non-invasive tests currently on the market are mainly for CRC, which already has cancerous tissue, rather than precancerous lesionsColonoscopy remains the primary detection of CRCLifeKit Prevent testing uses the company's proprietary 16S rRNA MultiTagDx screening technology to identify microbial DNA and RNA biomarkers associated with lower digestive tract tumorsIt uses non-invasive means to obtain samples from feces for analysisIf the test results are positive, the presence of rectal adenoma or CRC is indicated, followed by a diagnostic colonoscopy and polyps ectomyprevious clinical studieshave shown that LifeKit Prevention may be more accessible to patients and medical personnel than current CRC diagnosticsBased on the current results, LifeKit Prevention has high accuracy in colon cancer detection and, more importantly, in the detection of precancerous lesions that have not been detected in existing non-invasive testing methodsPositive test results from LifeKit Prevention can prompt high-risk patients who do not want to undergo colonoscopy to remove precancerous adenomas to prevent further development of cancer and reduce THE incidence and mortality of CRC"We are pleased to have this LifeKit Prevention test, a non-invasive diagnostic test that not only helps detect colorectal cancer, but also helps identify patients at risk of late adenoma." By identifying people at risk of precancerous lesions, we can stop and save lives before tissue cancer," said DrKeri Donaldson, CEO of Prescient Medicine HoldingsThis FDA finding confirms the uniqueness of our technology and the potential benefits our tests may offer to an increasing number of CRC patientsReferences: , FDA Grants DiscoverY Device To The Prescient Metabiomics LifeKit® Prevent Test for The Early Of Colon Polyps and Colon Cancer, Retrieved September 04, 2019, https://
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.